| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |